Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet

Enliven Therapeutics, Inc. (ELVN) closed the last trading session at $23.77, gaining 5.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $34 indicates a 43% upside potential. The average comprises four short-term price targets ranging from a low of $32 to a high of $38, with a standard deviation of $2.83. While the lowest estimate indicates an increase of 34.6% from the current pr ...